endothelial cells; proliferation; hypoxia; EPCs HYPOXIA CAUSES SIGNIFICANT structural remodeling of pulmonary arteries in persons living at high altitude (3) , and the contribution of hypoxia to those vascular changes is beyond question in a number of lung diseases (35) . Sustained exposure to hypoxia induces changes in the structure of pulmonary arteries, as well as in biochemical and functional phenotypes of each of the cell types composing the artery from larger, more proximal vessels to the most peripheral vessels in the interalveolar wall. The cellular and molecular mechanisms may vary at specific locations even within the pulmonary circulation. This is because the cellular composition of the arterial wall changes along the longitudinal axis within the pulmonary circulation (29) . Thus understanding of the vascular remodeling induced by hypoxia requires an evaluation of the cells participating at different levels along the vascular net.
Although the relationship between hypoxia and proliferation of pulmonary vascular smooth muscle cells (PVSMCs) has been well established (20) , it is controversial whether proliferation of pulmonary vascular endothelial cells (PVECs) is directly stimulated by hypoxia (31, 43) . The structural changes due to sustained exposure to hypoxia include muscularization of previously nonmuscular arterioles, increased medial thickness of muscular arterioles, adventitial hypertrophy, and deposition of additional matrix components such as collagen and elastin in the wall of pulmonary vessels (29, 30) . The other major aspect of structural changes caused by hypoxia is rarefaction or pruning, which means loss of small blood vessels (21) . Hypoxia-induced loss of blood vessels in the pulmonary circulation, a widely accepted paradigm, is in contrast to the facts that vascular endothelial growth factor (VEGF) and its receptors, which induce proliferation of endothelial cells, are expressed in the lung and that hypoxia leads to increased VEGF expression (34) . In addition, it has been also reported that chronic hypoxia causes an increase in the number of endothelial cells in intra-acinar vessels and capillaries, indicating new vessel formation (12) . The mature pulmonary circulation should be capable of angiogenesis when appropriately stimulated, although the erstwhile concept was that the adult pulmonary circulation was incapable of supporting the growth of new vessels.
Activated endothelial cells may participate in sprouting angiogenesis. Asahara and colleagues (6) reported that cells isolated with anti-CD34 or anti-Flk-1 can differentiate into endothelial cells in vitro, suggesting the presence of circulating endothelial progenitor cells (EPCs) that may be involved in vascular endothelial repair. Historically, the EPCs had been shown to derive from bone marrow (BM). It is believed that under homeostatic conditions these cells are released from the BM, circulate in the blood, and contribute to the regenerating process of tissues. However, there is increasing evidence to suggest that non-BM-derived cells with characteristics of stem/ progenitor cells exist in local tissues. Schniedermann and colleagues (25) have reported that EPCs with a high proliferative potential reside in the mouse pulmonary microcirculation and that these EPCs express CD133, the more immature marker protein. However, their potential location, identification, and functional role have not been clearly established.
To date, one technical limitation in this field has been the lack of a specific marker to identify EPCs, and one important question is the physiological or pathophysiological processes by which these EPCs could play a role. In addition, the role of EPCs may change according to the characteristics of stimuli, including hypoxia (22) . Taken together, whether resident EPCs or BM-derived EPCs play a major role in the angiogenic response of PVECs to hypoxia has yet to be determined. Our previous data suggested the substantial proliferation of PVECs in response to hypoxia. We hypothesized that PVECs might be enriched with EPCs that could be activated under hypoxia. To clarify the origin of hypoxia-reactive PVECs, cytological analysis using BM-transplanted mice expressing green fluorescent protein (GFP) was also performed.
METHODS

Animals and Exposure to Hypoxia
Seven-week-old male C57BL6 mice (Japan CLEA, Tokyo, Japan) were distributed into normoxic and hypoxic groups. All mice had free access to food and water. Mice in the hypoxic groups were housed in sealed acrylic chambers under 10% O 2 (6 l/min), which was maintained by an air generator (TEIJIN, Tokyo, Japan) for 1, 3, 5, or 7 days or 2 or 3 wk. O2 concentration was monitored continuously with an O2 analyzer (JKO-25ML II R; JIKCO, Tokyo, Japan). To avoid the effect of CO 2 and NH3 on mice, the environmental conditions were maintained by change of bedding materials and by using a CO2 absorber. All animal procedures were conducted under protocols approved by the Review Board for animal experiment of Chiba University.
BrdU Labeling for the Detection of Proliferating Cells
Bromodeoxyuridine (BrdU) is a thymidine analog incorporated into DNA of actively proliferating cells during the S-phase of the cell cycle. From the day before flow cytometry (FCM), mice were given 0.8 mg/ml BrdU (Sigma, St. Louis, MO) in their drinking water. The BrdU solution was prepared in sterile water, protected from light exposure. Moreover, 12 and 24 h before the assay, mice were intraperitoneally injected with 1 mg of BrdU in phosphate-buffered saline (PBS).
Lung Single Cell Suspension
For FCM analysis, lung cell dispersion was performed. After anesthesia was induced by intraperitoneal injection of pentobarbital, lungs were perfused from the right ventricle with PBS containing 10 U/ml heparin (Novo-Heparin; Mochida, Tokyo, Japan), and collected. The lungs were minced with scissors and subjected to enzymatic digestion: Dulbecco's modified Eagle medium (DMEM; Sigma) containing 1% of bovine serum albumin (Wako, Osaka, Japan), 2 mg/ml collagenase (Wako), 2.5 mg/ml Dispase II (Roche Diagnostics, Mannheim, Germany), and 100 g/ml DNase (Wako). The suspensions were incubated at 37°C on a shaker for 60 min and then filtered through a 100-m nylon mesh screen. After dispersion of lung cells, the total number of cells was counted.
Fluorescence-Activated Cell Sorting Analysis
The digested lung cells were pretreated with anti-CD16/32 antibody (BioLegend, San Diego, CA) to block Fc receptors and then stained with a mixture of fluorophore-conjugated antibodies in the dark at 4°C. The anti-mouse primary antibodies used were PE-Cy7-conjugated anti-CD31 (BioLegend), Alexa Fluor700-conjugated anti-CD45 (BioLegend), APC-conjugated anti-BrdU (BD Pharmingen, San Diego, CA), and biotinylated anti-CD34 (BioLegend). Irrelevant isotype-matched antibodies were used as controls. APC-conjugated streptavidin (BioLegend) was used as secondary antibody. To measure DNA degradation, the cells were incubated with 10 g/ml of Hoechst 34580 (Life Technologies, Grand Island, NY) for 30 min at 37°C, and 0.5 g/ml of propidium iodide (Sigma) was used to evaluate cell viability. We took 1ϫ10 6 cells per sample and 2ϫ10 5 events were recorded using a flow cytometer (FACS Canto II; BD Biosciences, San Jose, CA). FCM data was analyzed using FlowJo software (Tree Star, San Carlos, CA).
Reactive Oxygen Species Generation Assay
After surface staining the cells were incubated in PBS containing 40 M of dichlorofluorescein diacetate (DCF-DA; Life Technologies) for 30 min at 37°C, to measure intracellular reactive oxygen species (ROS).
ALDH Activity
To detect cellular aldehyde dehydrogenase (ALDH) activity, AL-DEFLUOR kit (STEMCELL Technologies, Vancouver, BC, Canada) was used according to the manufacturer's protocol.
Magnetic Cell Separation
For cell culture and DNA extraction from PVECs, PVECs defined as CD31
ϩ CD45 Ϫ cells were purified from whole lung cells by positive selection using the magnetic cell sorter (autoMACS; Miltenyi Biotec). Lungs from normoxic and hypoxia-exposed mice were processed into single-cell suspensions, as described above. The dissociated lung cells were incubated with anti-CD16/32 Ab (BioLegend) and then incubated with FITC-conjugated anti-CD31 antibody (BioLegend) for 60 min at 4°C followed by incubation with anti-FITC magnetic microbeads (Miltenyi Biotec) for 15 min at 4°C. Following filtration (100-m nylon mesh screen), labeled cells were sorted; the program "POSSELD," positive selection through two columns in the magnetic cell sorter, was run twice; and CD31-positive cells were collected. After cell separation, the percentage of CD31 ϩ CD45 Ϫ cells in sorted cells was confirmed by FCM. The purity was greater than 90%, as previously reported (41) .
Immunofluorescence Staining
The lungs perfused with optimum cutting temperature compound (OCT: SAKURA Finetek, Tokyo, Japan) were embedded in the compound and frozen in liquid nitrogen for tissue sectioning. Sevenmicrometer-thick frozen sections were examined.
The sections were fixed in acetone, blocked with the primary and secondary antibodies. The following primary antibodies were used: Alexa488-conjugated anti-CD31 (BioLegend), Alexa647-conjugated anti-CD45 (BioLegend), anti-Ki67 (Abcam, Cambridge, MA), and Alexa555-conjugated anti-GFP (Invitrogen, Carlsbad, CA). Alexa Fluor 488-conjugated anti-rat IgG (BioLegend), Alexa Fluor 555-conjugated anti-rabbit IgG (Life Technologies) and Alexa Fluor 647-conjugated anti-rabbit IgG (Life Technologies) were used as secondary antibodies, and cell nuclei were counterstained with Hoechst 34580 (Sigma). As negative control, isotype controls of each antibody were used. Stained slides were observed under a confocal fluorescence microscope (FluoView FV 10i; Olympus, Tokyo, Japan).
Histological Quantification
To determine the localization of proliferating PVECs under hypoxic conditions, we separated pulmonary vessels into two groups by morphology: "arterioles," defined as vessels with visible vascular lumen and elastic membrane, and "capillaries," defined as flattened vessels. The percentage of Ki67-positive cells in PVECs was evaluated in lungs from mice that were under hypoxic conditions for 7 days.
Quantitative PCR Analysis
Total RNA from whole lung cells and CD31 ϩ CD45 Ϫ cells was purified with the Nucleo Spin RNA XS and Nucleo Spin RNA II (MACHEREY-NAGEL, Diiren, Germany) according to the instructions provided by the manufacturer. The RNA was transcribed to cDNA by using SuperScript VILO Master Mix (Invitrogen). Quantitative real-time RT-PCR was performed with the Sequence Detection System ABI Prism 7300 (Applied Biosystems, Carlsbad, CA), by the SYBR Green method and the Universal Probe Library (UPL) method. The SYBR Green method includes primers (Sigma Genosys) and Fast SYBR Green Master Mix (Applied Biosystems). The UPL method includes primers (Sigma Genosys), Universal Probe Library Extension Set Version 04 (Roche), and FastStart Universal Probe Master (ROX) (Roche). The levels of gene expression in each sample were determined by the Ct method. The Ct values of each sample were normalized with Hprt as the internal control gene and relative gene expression level was calculated by the 2 Ϫ⌬⌬Ct method. Because an appropriate internal control gene needs to be used, the following candidates were screened: Actb, Gapdh, Hprt, Rps18, Ywhaz, and Oaz1. Among these genes, Hprt was selected as the suitable internal control because its range of gene expression alteration in normoxic and hypoxic PVECs was the smallest.
BM Transplantation
Wild-type C57BL6 mice, 5 wk of age, were lethally irradiated with 9.5 Gy of radiation divided into two doses of 5 Gy and 4.5 Gy given 5 h apart on the day before transplantation. Unfractionated BM cells (1ϫ10 7 cells) harvested from the donor mice and ubiquitously expressing GFP under CAG promoter (Japan SLC, Shizuoka, Japan) were intravenously injected into the recipient mice. More than 3 mo after BM transplantation, the percentage of GFP-positive cells in peripheral blood was confirmed. After confirmation of BM reconstitution, chimeric mice were kept in hypoxic chambers for either 1 or 3 wk.
BM Cell Infusion to Nonirradiated Mice
To address the potential influence of irradiation on BM-derived cell incorporation into PVECs, nonirradiated wild-type mice that were exposed to hypoxia and on days 2 and 6 were intravenously injected with 1ϫ10 7 BM cells from GFP-expressed mice. After 1 or 3 wk under hypoxic conditions, incorporation of the injected cells into the pulmonary vessels was assessed by FCM. Normoxic groups served as controls.
Evaluation of Circulating EPC
The number of circulating EPCs in peripheral blood was evaluated. Three hundred to 500 l of peripheral blood was collected from the inferior vena cava and mixed with 100 U of heparin (Mochida); then red blood cells were lysed by adding 0. 
Colony Formation Assay
PVECs were isolated from normoxic and hypoxia-exposed (day 7) mice as described above. These cells were seeded at a cell density of 1ϫ10 6 cells/well on gelatinized six-well plates (BD) supplemented with DMEM (Wako) containing 10% heated-inactivated fetal bovine serum (Wako), 1 mM 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid (Life Technologies), endothelial cell growth supplement (Sigma), Primocin (InvivoGen, San Diego), and 12 U/ml heparin (Mochida). Nine days after seeding, the colonies that had formed, defined as clusters of 30 or more cells, were counted.
Tube Formation Assay
Isolated PVECs suspended in endothelial cell basal medium-2 (EBM-2; Lonza, Walkersville, MD) supplemented with EGM-2 MV single aliquots (Lonza) containing 10% fetal bovine serum were seeded at a cell density of 4ϫ10 5 cells/well into 200 l/well Matrigel (BD)-coated chamber slides. These were analyzed for network formation by microscopy.
Statistical Analysis
Quantitative data are presented as means Ϯ SE. Comparison among groups was made by Student's t-test, Welch's t-test, oneway ANOVA, or Kruskal-Wallis test. GraphPad Prism software (version 6.03; GraphPad Software, San Diego) was used for statistical analysis and figure generation.
RESULTS
Transient Decrease of PVECs was Followed by an Increase in Hypoxic Animals
After murine lung cell dispersion, we counted the number of total lung cells and determined the percentage of subpopulations by FCM (Fig. 1A) . The total number of lung cells decreased on day 5 and then gradually increased to levels beyond the baseline count until 2 wk of hypoxia but decreased to baseline levels after 3 wk of hypoxia.
As an initial step to quantify subpopulations of lung cells, the percentage of subpopulations with different CD31 and CD45 expression patterns was analyzed in both unstained control and fluorescent antibody-stained cells (Fig. 1B) . Then the number of PVECs defined as CD31 
CD31
ϩ CD45 Ϫ cells among total cells)/100. The change in number of PVECs was similar to that of total lung cells during exposure to hypoxia (Fig. 1C) . After 2 wk under hypoxic conditions, the number of PVECs (161.3 Ϯ 16.3 cells/mice) was significantly higher compared with that on day 5 (85.0 Ϯ 2.63 cells/mice; P ϭ 0.03). However, the change in percentage of PVECs in whole lung cells was not significant (data not shown). The result of Hoechst dye staining is presented in Fig.  1D and shows that the percentage of apoptotic PVECs increased on day 5 under hypoxia (normoxic mice; 5.03 Ϯ 0.73%, vs. hypoxic mice; 8.83 Ϯ 1.11%).
Hypoxia During 1 wk Induced a Prominent Incorporation of BrdU into PVECs
To examine the effect of hypoxia on the proliferative activity of PVECs, hematopoietic cells (HCs) Fig. 2A . Under normoxia, BrdU-positive HCs accounted for 6.68 Ϯ 0.60%, whereas few BrdU-positive cells were observed among PVECs, epithelial cells, and PVSMCs (0.54 Ϯ 0.12, 0.59 Ϯ 0.18, and 0.38 Ϯ 0.07%, respectively). However, after a week under hypoxia, the percentage of BrdU-positive PVECs increased to Ͼ10% (Fig. 2B) . Moreover, the increase in the percentage of BrdU-positive PVECs was significantly higher compared with those in HCs, epithelial cells, and PVSMCs (Fig. 2, C and D) .
Ki67-Positive Cells Were Detected among PVECs after 1 wk under Hypoxia, Especially in Capillary Vessels
To clarify the localization of proliferating cells in hypoxic lungs, frozen lung samples were immunohistochemically stained for Ki67, CD31, and CD45 (Fig. 3A) . Like BrdU, Ki67 is also a marker for proliferation. However, Ki67 protein is present during all active phases of the cell cycle (G1, S, G2, and mitosis). After a week under hypoxia, Ki67-positive cells were detected among PVECs, especially in capillary vessels. In contrast, the majority of Ki67-positive cells were HCs and few Ki67 ϩ CD31 ϩ cells were observed under normoxia and after 2 or 3 wk under hypoxia. These results supported those of the BrdU study by FCM analysis.
Histological quantification showed that significant proliferation of PVECs occurred in the capillaries compared with arterioles after a week under hypoxia (Fig. 3B) .
Percentage of GFP-positive PVECs Was Low and Constant during 3 wk under Hypoxia in BM-Transplanted Mice
We next investigated whether BM-derived cells directly participate in the pulmonary vasculature response during hypoxia. BM obtained from GFP-expressing mice was transplanted to wild-type irradiated mice. After dispersion of the lung cells, PVECs and HCs were analyzed by FCM as described above. Representative panels of FCM analyses showing BM reconstitution and the percentage of BMderived cells in PVECs and HCs are presented (Fig. 4, A and B) . BM-transplanted mice showed a high degree of chimerism (96.1 Ϯ 0.31%). Under normoxia, GFP-positive PVECs accounted for only 1.14 Ϯ 0.17%, whereas that of GFP ϩ HCs was 78.7 Ϯ 1.80% (Fig. 4C) . The percentages of GFP-positive PVECs and HCs were nearly constant during 3 wk under hypoxia. The number of GFP ϩ /BrdU ϩ PVECs was also low and constant during hypoxia (Fig. 4, D and E) .
Little Engraftment of BM-Derived Cells Was Detected in PVECs of Chimeric Mice under Hypoxia
Immunohistochemical analysis was used to evaluate frozen sections from control and hypoxic GFP-chimeric lungs to determine the extent of mobilization of BM-derived cells. Under normoxic conditions, few GFP ϩ
CD31
ϩ cells were observed and the majority of GFP-positive cells coexpressed CD45 in the lungs. Similarly, few GFP ϩ CD31 ϩ cells were detected in lungs after 1 or 3 wk under hypoxia. In contrast, GFP ϩ CD45 ϩ cells were predominant in peripheral lung tissue (Fig. 5A) .
The immunohistological distribution of Ki67-positive cells was examined in the lungs of GFP-chimeric mice. 
ϩ cells were detected in GFP-chimeric mice as well as in nonchimeric mice. However, few GFP ϩ Ki67 ϩ CD31 ϩ cells were observed after a week under hypoxia, and GFP ϩ Ki67 ϩ cells were presumed to be mostly HCs (Fig. 5B) , suggesting that most of Ki67 ϩ CD31 ϩ cells did not derive from bone marrow.
There Was Little Tissue Integration of Injected BM-Derived Cells in the Nonirradiated Hypoxic Mice
To further address the potential influence of irradiation on the incorporation of BM-derived cells into pulmonary vessels, we intravenously injected BM cells harvested from GFPexpressing mice into nonirradiated mice that were exposed to hypoxia. Representative panels of FCM analyses showing the percentage of GFP-positive cells in PVECs and HCs are presented (Fig. 6, A and B) . Almost no GFP-positive PVECs were observed at any time point in either normoxic or hypoxic lungs (Fig. 6C) . GFP-positive HCs increased after exposure to hypoxia for 1 wk and in controls. In addition, the percentage of GFP-positive HCs was not significantly higher in hypoxic lungs compared with that in normoxic lungs. However, GFPpositive HCs nearly disappeared after 3 wk under hypoxia and in controls (Fig. 6D) .
Hypoxia Induced Mobilization of Circulating EPCs
Under hypoxia, the gene expression of Cxcl12 and Pgf, which are related to the mobilization of EPCs (38, 40) , was significantly increased in whole lung cells (Fig. 7A) (Fig. 8A) . The percentage of CD31-positive cells in isolated PVECs were Ͼ90% in normoxic and hypoxia-exposed groups. Hypoxia increased gene expression of Prom1 (CD133) and Kit by 2 wk under hypoxia. In addition, that of Cd34 significantly increased from 3 days until 2 wk. Actually, CD34-positive PVECs increased gradually until 2 wk as assessed by FCM (Fig. 8B) .
Colony-and tube-forming capacities. EPCs possess an intrinsic ability to form colonies and vascular networks in vitro. To confirm that the lung contains endothelial cells with a high proliferating capacity as previously reported (25), PVECs were isolated from normoxic and hypoxic mice by magnetic cell sorting as described above. The purity of PVECs isolated from normoxic and hypoxic mice was determined as previously mentioned (95.8 and 97.4%, respectively). The colony formation assay was carried out to determine the proliferating capacity of PVECs in both groups. Hypoxic PVECs proliferated rapidly compared with normoxic PVECs from day 1. Moreover, the number of colonies with 30 or more spindle-shaped and cobblestone-like cells per well, in which 1ϫ10 6 cells were seeded, was compared between groups. Representative micrographs of colony formation in hypoxic PVECs are shown in Fig. 8C . The capacity to form colonies by hypoxic PVECs was significantly higher than that by normoxic PVECs on day 9. To test the capability of proliferating PVECs to form capillary tubes, we performed tube formation assay on Matrigel-coated chamber slides (Fig. 8D) . We observed spheroid and adherent cells within 7 days in both groups. Hypoxic PVECs formed spheres at a higher frequency than normoxic PVECs. After 7 days of culture, hypoxic PVECs began to form tubelike networks, which expanded until day 15, around the spheroid. In contrast, normoxic PVECs failed to generate tubes even by day 28 under the same culture conditions. ROS generation. EPCs have been presumed to be resistant to many stressors including oxidative stress. We determined the amount of intracellular ROS in both normoxic and hypoxic PVECs by FCM analysis using DCF-DA, previously reported as an efficient quantitative marker for cellular oxidant stress (Fig. 9A) (7) . Geometric mean fluorescence intensity of DCF-DA gradually increased until day 5 under hypoxia (1.2-fold) and then decreased to 50% of that observed under normoxia. In addition, the gene expression of Gpx2 increased in hypoxia-exposed PVECs (Fig. 9B) .
ALDH activity. Increased activity of ALDH has been confirmed in hematopoietic and neural stem/progenitor cells. AL-DEFLUOR fluorescence, which represents ALDH activity, was therefore evaluated in PVECs (Fig. 9C) . Under normoxia, 1.05 Ϯ 0.11% of PVECs expressed ALDH activity. The percentage of ALDEFLUOR-positive PVECs increased by 3 days under hypoxia (1.48 Ϯ 0.27%); however, it then gradually decreased. The expression of Aldh1b1, a gene related to ALDH activity, was enhanced in regenerating PVECs (Fig. 9D) .
Expression of drug resistance genes. One mechanism of cellular protection in EPCs is expression of efflux pumps, which are products of drug (i.e., toxin) resistance genes. Figure  9E shows that the relative expression of several ATP-binding cassette (ABC) transporters such as Abcb1a, Abcb1b, and Abcg1 were slightly enhanced in hypoxic PVECs.
DISCUSSION
The results of the present study demonstrate that PVECs responded to exposure to hypoxia for 1 wk and proliferated especially in the capillaries. It is well established that hypoxia induces proliferation of mesenchymal cells such as PVSMCs and fibroblasts (26, 28) while it remains controversial whether hypoxia affects proliferation of PVECs and epithelial cells (39, 43) . Therefore, the hypoxia-induced proliferation of lung constitutive cell populations such as endothelial and epithelial cells has been analyzed in vitro (10); however, the effects of hypoxia on these cells in vivo have not been quantitatively evaluated. In the present study, under steady conditions, the proliferative ability of PVECs was comparable to that of epithelial and mesenchymal cells, which exhibit a relatively low proliferative rate (23). After 5 or 7 days under hypoxia, most of these cell populations including HCs showed the highest incorporation of BrdU. The increase in the rate of BrdU-positive PVECs was the most remarkable of all cell populations. The present results support the proliferation of PVECs, epithelial cells, and mesenchymal cells in the face of acute and subacute hypoxia, with an especially notable increase in PVEC proliferation compared with other cell components.
The present study showed the proliferating PVECs localized dominantly in the capillaries by immunohistochemical staining. In the past, the adult pulmonary circulation was believed to be incapable of supporting the growth of new vessels. The structural changes induced by hypoxia have been thought to include loss of small blood vessels (29) . Nevertheless, it has also been reported that hypoxia induces capillary angiogenesis in the adult lung in vivo (12, 13) . In the lung, microvascular endothelial cells proliferate approximately twice as fast as macroarterial endothelial cells (16) Moreover, PVEC-derived angiocrine signals might facilitate regenerative alveologenesis as shown in rats subjected to unilateral pneumonectomy (9) . The increased capillary bed with accompanied growth of the alveolar epithelium could be an important contribution for adapting to hypoxia by increasing the diffusing capacity of the lung thanks to an expansion of the effective surface area of the and Flk-1 ϩ CD133 ϩ cells in peripheral blood increased on day 7, followed by a decrease to the same level observed under normoxia. Values are means Ϯ SE, *P Ͻ 0.05. alveolar gas exchange membrane (18) . Thus the robust proliferation of PVECs observed in this study might play a beneficial role in the adaptive response to chronic hypoxia.
Though usually considered to be quiescent, the marked proliferation of the PVECs, whose average lifespan is more than 1 year (1) to adapt a hypoxic environment, reminds us of the participation of EPCs, since EPCs could contribute to angiogenesis and/or vasculogenesis (6) . Although BM-derived EPCs are surely important for angiogenesis in many pathophysiological situations (15, 27) , the presence of non-BMderived progenitor cells has also been reported. Recent evidence indicates that the vessel wall contains progenitor cells, which have a potential to maintain and repair the endothelium (32, 45) . Ingram et al. (14) proposed that vascular wall resident progenitor cells in the intima of the umbilical vein and aortic vessel wall could contribute to endothelial cell formation. However, the origin, functions, and phenotypes of EPCs are still controversial. In the present study, to discriminate whether the proliferating PVECs in hypoxic animals derive from BM or resident tissues, we generated BM chimeric mice by the transplantation of BM cells expressing GFP into lethally irradiated wild-type mice. Although hypoxia induced similar proliferation of PVECs in chimeric mice and in wild-type mice, the percentage of GFP-positive PVECs was low and constant during hypoxia as shown by FCM and immunohistochemical analysis. Moreover, to avoid the radiation-induced inflammation and dysfunction of endothelium in recipient mice, BM cells from GFP-expressing mice were repeatedly injected intravenously into wild-type mice during hypoxic exposure, resulting in almost no BM cell incorporation into the endothelium of normoxic or hypoxic mice. These facts indicate that the origin of proliferating PVECs under hypoxia could be local tissue including tissue-resident EPCs.
In this present study, hypoxic PVECs displayed EPC-like characteristics, including neovasculogenic capacity (in vitro) and antioxidative capacity as indicated by a decline in cellular ROS. In previous studies, microvascular endothelial cells could be enriched in the tissue-resident EPCs, which possess prolif- erative capacity as well as the abilities to form colonies and a vascular network (2, 19, 42) . In addition, expression of ABC transporter related to drug resistance (36), high ALDH activity (4, 11) , and ROS-scavenging capability (8, 37) are considered to be functions of progenitor cells. A different study reported that the neovascularization capacity of EPCs from hypoxic mice was impaired compared with EPCs from control mice (17) . In our present study, although several functional features of EPCs were augmented by exposure to hypoxia, others, including ALDH activity and drug resistance, were not. EPCs appear to have a tissue-engineering potential under hypoxic stimulation, although the exact mechanisms of EPCs contribution remain unknown.
The fact that few BM-derived EPCs were incorporated into the hypoxic pulmonary endothelium despite the increased number of circulating EPCs indicates that BM-derived EPCs may not participate in the hypoxic endothelial response. Using the hypoxic animal model, several reports showed an increased number of circulating EPCs. However, it has been conflicting whether the circulating EPCs become incorporated into the endothelium, especially based on immunohistochemical investigations (17, 24) . The present study showed that hypoxia upregulated gene expression of EPC migrating factors such as Cxcl12 and Pgf in whole lung cells, and consequently the number of circulating EPCs increased at the same time proliferation of PVECs occurred. These data suggest that local tissue factors are the main participants in PVEC proliferation, whereas BM-derived endothelial cell recruitment may be limited. Circulating EPCs have been considered to consist of at least two distinct phenotypes, the early-and late-outgrowth EPCs. Late-outgrowth EPCs that appear after 14 -21 days of culture have a high proliferative rate and the capacity to form vessel structures. In contrast, although the early-outgrowth EPCs identified after 4 -7 days of culture have a low proliferative capacity, they secrete potent angiogenic factors that accelerate the proliferation and migration of late outgrowth EPCs, preexisting endothelial cells, and tissue-resident progenitor cells (5, 15, 33, 44) . In our study, circulating EPCs could be considered to have characteristics of early outgrowth EPCs. In the development of revascularization therapy with EPCs, these findings suggest the importance of elucidating the mechanism of EPCs-endothelial cells interactions.
A couple of limitations should be mentioned in the present study. We showed the existence of tissue-resident EPCs, which proliferated under hypoxia in the lung. However, these cells were only a small fraction of PVECs. The functional features of EPCs that we indicated might be affected by existence of non-EPCs, since characteristics of proliferating PVECs were analyzed by use of whole PVECs. Expression of stem cell markers, such as Prom1 and c-kit, did not show a significant increase. In the tube formation assay, hypoxic PVECs formed tube structures later than the timeframe previously reported for EPCs and the structures themselves were defective. In addition, our method using standardized protocol with chimeric mice cannot exclude the possibility that tissue resident progenitor cells may have been mobilized from organs such as the liver and intestine. Furthermore, the molecular mechanism by which EPCs would regulate PVECs proliferation has not been defined.
In conclusion, the present study demonstrates that hypoxia induced notable proliferation of PVECs, especially in capillary vessels. We conclude that tissue-resident EPCs might play a direct role in hypoxic response of PVECs, whereas BMderived EPCs participate indirectly. As for the lung tissue destruction/repair in acute respiratory failure and chronic hypoxia-induced lung involvement including pulmonary vascular remodeling, it is necessary to elucidate the pathobiological conditions and find therapeutic targets to analyze the cells with high activity that constitute lung tissue. Therefore, this investigation of the origin and characteristics of proliferating PVECs in acute and prolonged hypoxia is important for further research.
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